Cronos stock plunges 30% after Citron short call, report of Trump anti-marijuana effort

Cannabis stocks dropped Thursday after famed short seller Andrew Left’s Citron Research published a “reality check” for Canada-based weed company Cronos Group Inc. and the rest of the sector, and a report of a federal effort to fight marijuana legalization.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.